Cigna Delivers Strong Q3, Accelerate To One Program Targets $3B Savings By 2030
Cigna shares fell after Q3 results; analysts remain bullish, citing raised guidance, 2027 growth, and strong demand.
Stocks · News reference
Cell Impact to Conduct Forming Tests on Nanocrystalline Titanium
Cell Impact AB (publ) announced it will perform forming tests on Japanese-produced nanocrystalline titanium at the request of undisclosed customers.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Evercore ISI Group Maintains In-Line on Cigna Group, Raises Price Target to $320
Cigna Tops Q3 Estimates, Raises 2026 Outlook as It Flags 2027 Headwinds
Cigna beat Q3 estimates with $7.98 adjusted EPS on $73.7 billion revenue, raised its 2026 outlook and still expects at least 10% EPS growth in 2027.
Cigna Group Q3 2026 Earnings Call Transcript
Cigna Group (NYSE:CI) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
Cigna Exec Says Expects Evernorth Earnings To Grow In Low Single Digits In 2027
Cigna Exec Says Expects About $200M Headwind In 2027 From Exiting Affordable Care Act Exchange Market